Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7195 USD | +2.79% | +6.51% | -19.16% |
Evolution of the average Target Price on Alzamend Neuro, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Alzamend Neuro, Inc.
Maxim | |
Ascendiant Capital |
EPS Revisions
- Stock Market
- Equities
- ALZN Stock
- Consensus Alzamend Neuro, Inc.